The other study also indicated that TGF-β1 may accelerate the risk of late-onset AD and AD-related depression [32], and in addition it was highly implicated in causing Aβ plaque formation and cognitive and cerebrovascular alterations [33, 34]. The gene discussed is TGFB1; the disease is depressive symptom measurement.